1Fields RC,Coit DG.Evidence-based follow-up for the patient withmelanoma[J].Surg Oncol Clin N Am,2011,20(1): 181-200.
2Terhune MH,Swanson N,Johnson TM.Use of chest radiographyin the initial evaluation of patients with localised melanoma[J].Arch Dermatol,1998,134(5):569-572.
3Bessoud B,Lassau N,Koscielny S,et al.High-frequency sonogra-phy and color Doppler in the management of pigmented skin Ie-sions[J].Ultrasound Med Biol,2003,29(6): 875-879.
4Machet L,Nemeth-Normand F,Giraudeau B,et al.Is ultrasoundlymph node examination superior to clinical examination in mela-noma follow-up? A monocentre cohort study of 373 patients[J].BrJ Dermatol,2005,152(1): 66-70.
5Rossi CR,Mocellin S,Scagnet B,et al.The role of preoperative ul-trasound scan in detecting lymph node metastasis before sentinelnode biopsy in melanoma patients[J].J Surg Oncol,2003,83(2)?80-84.
6Finkelstein SE,Carrasquillo JA,Hoffman JM,et al.A prospectiveanalysis of positron emission tomography and conventional imagingfor detection of stage IV metastatic melanoma in patients undergo-ing metastasectomy[J].Ann Surg OncoU2004,11(8):731-738.
7Miranda EP,Gertner M,Wall J,et al.Routine imaging of asympto-matic melanoma patients with metastasis to sentinel lymph nodesrarely identifies systemic disease[J].Arch Surg,2004,139(8):831-837.
8Muller-Horvat C,Radny P,Eigentler TK,et al.Prospective com-parison of the impact on treatment decisions of whole body mag-netic resonance imaging and computed tomography in patients withmetastatic malignant melanoma[J].Eur J Cancer,2006,42(3):342-350.
9Abbott RA,Acland KM,Harries M,et al.The role of positron e-mission tomography with computed tomography in the follow-upof asymptomatic cutaneous malignant melanoma patients with ahigh risk of disease recurrence[J].Melanoma Res,2011,21(5):446-449.
10Patnana M,Bronstein Y,Szklaruk J,et al.Multimethod imaging,staging and spectrum of manifestations of metastatic melanoma[J].Clin Radiol,2011,66(3):224-236.
